PETS240920C2500
- 1.25
- 0.000.00%
PetMed Express Newsroom
Morgan Stanley Reaffirms Their Sell Rating on Petmed Express (PETS)
PetMed Express Analyst Ratings
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5
Petmed Express: Hold Rating With Cautious Outlook Amidst Management Changes and Competitive Challenges
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7
PetMed Express Analyst Ratings
Morgan Stanley Lowers Price Target on PetMed Express to $3.50 From $6.50, Maintains Underweight Rating
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), MiMedx Group (MDXG) and Petmed Express (PETS)
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Dynatronics (DYNT) and Silk Road Medical (SILK)
PetMed Express Analyst Ratings
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating
Petmed Express (PETS) Gets a Buy From Lake Street
PetMed Express Analyst Ratings
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating
PetMed Express Analyst Ratings
Morgan Stanley Reiterates Underweight on PetMed Express, Maintains $17 Price Target
PetMed Express Analyst Ratings
Lake Street Initiates Coverage On PetMed Express With Buy Rating, Announces Price Target of $20
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Petmed Express (PETS) and Petco Health and Wellness Company (WOOF)